Get the Stockscreener App
9.47
0.74%
0.07
After Hours:
9.51
0.04
+0.42%
Avita Medical Inc Stock (RCEL) Latest News
AVITA Medical (NASDAQ:RCEL) adds US$24m to market cap in the past 7 days, though investors from five years ago are still down 81% - Simply Wall St
Avita medical director Suzanne Crowe buys $6,390 in stock - Investing.com
(RCEL) Investment Report - Stock Traders Daily
Avita Gets FDA Nod For Device - San Fernando Valley Business Journal
Wound Skin Substitutes Market Forecast to 2030: Chronic Wound Burden Spurs Growth in Advanced Wound Care Technologies - Yahoo Finance
FY2024 EPS Forecast for AVITA Medical Decreased by Analyst - Defense World
Cantor Fitzgerald Expects Weaker Earnings for AVITA Medical - MarketBeat
Brokers Set Expectations for AVITA Medical FY2025 Earnings - Defense World
Cantor Fitzgerald Predicts AVITA Medical FY2025 Earnings - MarketBeat
Burns Pipeline 2024: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight | MediWound, Kaken Pharma, Kerecis, Medline, Mallinckrodt Pharma, Avita Medical, Vericel Corp - The Globe and Mail
AVITA Medical's shares sink 19% after another forecast cut - MSN
Short Interest in AVITA Medical, Inc. (NASDAQ:RCEL) Rises By 25.9% - MarketBeat
AVITA Medical, Inc. (NASDAQ:RCEL) Holdings Boosted by Barclays PLC - Defense World
Barclays PLC Grows Stock Holdings in AVITA Medical, Inc. (NASDAQ:RCEL) - MarketBeat
(RCEL) Investment Analysis - Stock Traders Daily
Why Avita Medical, Cettire, Domino's Pizza, and Star shares are falling today - MSN
AVITA Medical’s Growth Struggles Amplify Financial Risks (NASDAQ:RCEL) - Seeking Alpha
Investors Burned By AVITA Medical's Sales Miss: I'm Even More Bullish - Seeking Alpha
AVITA Medical: A Dip Buy As 2025 Looks Bullish With Cohealyx And RECELL GO Mini - Seeking Alpha
Lake Street Capital Issues Pessimistic Forecast for AVITA Medical (NASDAQ:RCEL) Stock Price - Defense World
D. Boral Capital Reiterates Buy Rating for AVITA Medical (NASDAQ:RCEL) - Defense World
ASX shares plunge but remain undervalued - Morningstar.com.au
AVITA Medical, Inc. (RCEL): A Bull Case Theory - Insider Monkey
AVITA Medical's SWOT analysis: regenerative medicine stock faces growth hurdles - Investing.com Australia
AVITA Medical’s SWOT analysis: regenerative medicine stock faces growth hurdles - Investing.com Nigeria
AVITA Medical's SWOT analysis: regenerative medicine stock faces growth hurdles By Investing.com - Investing.com South Africa
Why AVITA Medical, Lovisa, Star, and Westgold shares are sinking today - The Motley Fool Australia
Lake Street cuts Avita Medical stock target, retains buy rating By Investing.com - Investing.com Canada
Avita falls 19% on earnings downgrade - Geelong Advertiser
AVITA Medical (NASDAQ:RCEL) Price Target Cut to $14.00 by Analysts at Lake Street Capital - MarketBeat
Avita Medical Cuts Annual Sales Forecast On Softer Demand From Hospitals - Benzinga
AVITA Medical Cuts Forecast Again, Shares Tumble - Finimize
AVITA Medical Shares Slump on Lowered Outlook - MarketWatch
AVITA Medical's (RCEL) "Buy" Rating Reiterated at D. Boral Capital - MarketBeat
Investors wipe $110m off AVITA Medical shares as full-year revenue target downgraded - Business News Australia
Australian Shares Rise as November Inflation Data Signals Easing Potential; Avita Medical Lowers Revenue Guidance - Marketscreener.com
Why AVITA Medical, Block, Computershare, and GQG Partners shares are falling today - MSN
AVITA Medical stock slides 14% on lowered guidance - MSN
AVITA Medical (ASX:AVH) Updates Q4 and FY2024 Revenue Guidance - The Capital Club
Why did this ASX All Ords stock just crash 17%? - MSN
0.64%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):